<DOC>
	<DOCNO>NCT00416390</DOCNO>
	<brief_summary>RATIONALE : Chemoprevention use certain substance keep cancer forming , grow , come back . Eating diet high lycopene , substance find tomato tomato product , may keep cancer form grow . Collecting store sample blood patient cancer study laboratory may help doctor learn change may occur DNA identify biomarkers related cancer . PURPOSE : This randomized clinical trial study well lycopene work treat patient prostate cancer benign prostatic hyperplasia .</brief_summary>
	<brief_title>Lycopene Treating Patients With Prostate Cancer Benign Prostatic Hyperplasia</brief_title>
	<detailed_description>OBJECTIVES : - Assess ability prostatic tissue accumulate dos lycopene patient prostate cancer benign prostate hyperplasia . - Determine whether steady state level DNA oxidation blood prostate tissue responsive lycopene dosing . - Investigate effect lycopene dose lipid peroxidation marker malondialdehyde serum . - Assess importance measure multiple DNA oxidation product biomarkers oxidative stress chemoprevention . - Determine significance DNA oxidation product blood indicator oxidative stress prostate . - Measure prostate blood uptake chemoprevention agent lycopene . OUTLINE : This randomize , double-blind , placebo-controlled study . Patients randomize 1 2 treatment arm . - Arm I : Patients receive oral lycopene daily 3 week . - Arm II : Patients receive oral placebo daily 3 week . In arm , patient undergo biopsy confirm diagnosis prostate cancer benign prostatic hyperplasia 3 week study therapy . Blood sample collect baseline surgery biomarker/laboratory study . PROJECTED ACCRUAL : A total 120 patient accrue study .</detailed_description>
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Hyperplasia</mesh_term>
	<mesh_term>Prostatic Hyperplasia</mesh_term>
	<mesh_term>Lycopene</mesh_term>
	<mesh_term>Carotenoids</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Diagnosis 1 following : Prostate cancer Benign prostate hyperplasia High blood level prostatespecific antigen Enlarged prostate PATIENT CHARACTERISTICS : Not specify PRIOR CONCURRENT THERAPY : Not specify</criteria>
	<gender>Male</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2007</verification_date>
	<keyword>benign prostatic hyperplasia</keyword>
	<keyword>stage I prostate cancer</keyword>
	<keyword>stage IIB prostate cancer</keyword>
	<keyword>stage IIA prostate cancer</keyword>
	<keyword>stage III prostate cancer</keyword>
	<keyword>stage IV prostate cancer</keyword>
</DOC>